DEVELOPING IN-HOUSE, POINT-OF-CARE MANUFACTURED ANTI-CD19 CHIMAERIC ANTIGEN RECEPTOR (CAR)-T CELLS

被引:0
|
作者
Chan, Nelson Chun Ngai [1 ,2 ]
Loaiza, Sandra [1 ,2 ]
Uddin, Shab [1 ,2 ]
Aina, Edward [1 ,2 ]
Cook, Lucy [3 ]
Palanicawandar, Renuka
Bara, Anna [4 ]
Olavarria, Eduardo [3 ]
Apperley, Jane [3 ]
Karadimitris, Anastasios [3 ]
机构
[1] Imperial Coll Healthcare NHS Trust, John Goldman Ctr Cellular Therapies, London, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Imperial Coll London, Ctr Haematol, London, England
[4] Natl Inst Hlth Res Imperial Clin Res Facil, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P085
引用
收藏
页码:209 / 210
页数:2
相关论文
共 50 条
  • [31] Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
    Morita, Daisuke
    Nishio, Nobuhiro
    Saito, Shoji
    Tanaka, Miyuki
    Kawashima, Nozomu
    Okuno, Yusuke
    Suzuki, Satoshi
    Matsuda, Kazuyuki
    Maeda, Yasuhiro
    Wilson, Matthew H.
    Dotti, Gianpietro
    Rooney, Cliona M.
    Takahashi, Yoshiyuki
    Nakazawa, Yozo
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 8 : 131 - 140
  • [32] Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration
    Malakhova, Ekaterina
    Pershin, Dmitriy
    Kulakovskaya, Elena
    Vedmedskaia, Viktoria
    Fadeeva, Mariia
    Lodoeva, Oyuna
    Sozonova, Tatiana
    Muzalevskii, Yakov
    Kazachenok, Alexei
    Belchikov, Vladislav
    Shelikhova, Larisa
    Molostova, Olga
    Volkov, Dmitry
    Maschan, Michael
    CYTOTHERAPY, 2024, 26 (06) : 567 - 578
  • [33] LOW-DOSE CHEMOTHERAPY FOLLOWED BY ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS INDUCES REMISSIONS IN PATIENTS WITH ADVANCED LYMPHOMA
    Kochenderfer, J. N.
    Somerville, R. P.
    Lu, T.
    Shi, V.
    Yang, J. C.
    Sherry, R. M.
    Klebanoff, C. A.
    Kamula, U. S.
    Goff, S. L.
    Bot, A.
    Rossi, J.
    Sherman, M.
    Perez, A.
    Xue, A.
    Feldman, T.
    Friedberg, J. W.
    Roschewski, M. J.
    Feldman, S.
    McIntyre, L.
    Toomey, M. A.
    Rosenberg, S. A.
    HAEMATOLOGICA, 2016, 101 : 318 - 318
  • [34] A safe and potent anti-CD19 CAR T cell therapy
    Zhitao Ying
    Xue F. Huang
    Xiaoyu Xiang
    Yanling Liu
    Xi Kang
    Yuqin Song
    Xiaokai Guo
    Hanzhi Liu
    Ning Ding
    Tingting Zhang
    Panpan Duan
    Yufu Lin
    Wen Zheng
    Xiaopei Wang
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Chen Zhang
    Weiping Liu
    Lijuan Deng
    Shunyu Gao
    Lingyan Ping
    Xuejuan Wang
    Nina Zhou
    Junqing Zhang
    Yulong Wang
    Songfeng Lin
    Mierzhati Mamuti
    Xueyun Yu
    Lizhu Fang
    Shuai Wang
    Haifeng Song
    Guan Wang
    Lindsey Jones
    Jun Zhu
    Si-Yi Chen
    Nature Medicine, 2019, 25 : 947 - 953
  • [35] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [36] A safe and potent anti-CD19 CAR T cell therapy
    Ying, Zhitao
    Huang, Xue F.
    Xiang, Xiaoyu
    Liu, Yanling
    Kang, Xi
    Song, Yuqin
    Guo, Xiaokai
    Liu, Hanzhi
    Ding, Ning
    Zhang, Tingting
    Duan, Panpan
    Lin, Yufu
    Zheng, Wen
    Wang, Xiaopei
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Gao, Shunyu
    Ping, Lingyan
    Wang, Xuejuan
    Zhou, Nina
    Zhang, Junqing
    Wang, Yulong
    Lin, Songfeng
    Mamuti, Mierzhati
    Yu, Xueyun
    Fang, Lizhu
    Wang, Shuai
    Song, Haifeng
    Wang, Guan
    Jones, Lindsey
    Zhu, Jun
    Chen, Si-Yi
    NATURE MEDICINE, 2019, 25 (06) : 947 - +
  • [37] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
  • [38] Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
    An, Na
    Tao, Zhongfei
    Li, Saisai
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    ONCOTARGET, 2016, 7 (09) : 10638 - 10649
  • [39] Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
    Arroyo-Rodenas, Javier
    Diez-Alonso, Laura
    Falgas, Aida
    Martinez-Moreno, Alba
    Gil-Etayo, Francisco Javier
    Aguilar-Sopena, Oscar
    Velasco-Sidro, Miriam
    Bravo-Martin, Clara
    Ramirez-Fernandez, Angel
    Jimenez-Reinoso, Anais
    Blanco, Belen
    Roda-Navarro, Pedro
    Bueno, Clara
    Menendez, Pablo
    Alvarez-Vallina, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Deep Serological Profiling of SLE Patients Treated with anti-CD19 CAR T Cells
    Basu, Samik
    Nunez, Daniel
    Patel, Darshil
    Volkov, Jenell
    Vorndran, Zachary
    Wong, Steven
    Mackensen, Andreas
    Schett, Georg
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2951 - 2952